Pearl Bio
Stamford, US · Founded 2020 · Delaware corporation · 1 known investors
Pearl Bio develops technologies for genome engineering, ribosome engineering, and biomanufacturing to enable production of novel proteins, chemicals, and materials for biotechnology and medicine.
Founders & leadership
FI

Farren IsaacsCo-Founder and Science Advisor
MJ

Michael JewettCo-Founder and Science Advisor
AC

Amy Cayne SchwartzCo-Founder, COO & CBO
MG
Merton GollaherExecutive Officer
GC

George ChurchScience Advisor
JR

Jesse RinehartScience Advisor
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$4.1MraisedOct 2021 · 3 investors · BiotechnologyRule 506(b)
▶$4.1MraisedOct 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Merton GollaherExecutive Officer
- Farren IsaacsExecutive Officer, Director
- Michael JewettExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.1M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Merck bets up to $1B on Pearl's 'smart' biomaterial jewels as biotech begins to raise fresh funds - Center for Synthetic Biologysyntheticbiology.northwestern.edu · 2024
- Pearl Bio Inks Collaboration With Merck - Merck.commerck.com · 2024
- Pearl Bio Secures Breakthrough IP for Multi-Functionalized Biologics - BioSpacebiospace.com · 2023
- About Us | Pearl Biopearlbio.com · 2022
